COVID-19 Update – Critical Care and Pandemic Response
COVID-19 Update – Critical Care and Pandemic Response
In the midst of rising COVID-19 case rates globally, Derek C. Angus, MD, MPH and Rochelle P. Walensky, MD, MPH return to JAMA's Q&A series to update viewers on developments in the pandemic and the critical care management of COVID-19 patients. Dr. Angus is Chief Health Care Innovation Officer at @upmc, Professor and Chair of Critical Care Medicine, and a senior JAMA editor. Dr. Walensky is Chief of Infectious Diseases at @MassGeneralHospital and a Professor at @Harvard Medical School. Recorded November 19, 2020.Topics discussed in this interview:
0:00 Introduction
0:54 US COVID-19 data update
1:26 Intubation and current standard of care
4:37 Corticosteroids
7:30 Therapies (steroids, remdesivir, tocilizumab)
10:21 Questions about remdesivir
12:30 Tocilizumab trials and press releases
17:07 Making decisions based on press releases vs clinical trials
19:18 Potential of additional therapies (cyclosporine, interferon beta, etc.)
23:44 Pre-Thanksgiving surge in cases
26:46 What is sustainable in prevention and hospital capacity
31:30 mRNA vaccines (Pfizer and Moderna) and distribution
35:11 Safety data and mRNA vaccines
• Earn Free CME credits by watching JAMA Livestreams and completing a brief questionnaire. Claim 0.5 credits for each video at https://ja.ma/covidqa
• Coronavirus Resource page from the JAMA Network: https://ja.ma/covidyt
• To watch all the #JAMALive Q&A's Visit: https://ja.ma/covidqaytpl
• Don't forget to hit subscribe or click https://ja.ma/subscribe
---------------------------------------------------------------------------------
For more from JAMA
• https://www.jama.com
• https://www.facebook.com/JAMAJournal
• https://www.twitter.com/JAMA_Current
• https://www.linkedin.com/company/jamanetwork
Follow the JAMA Network
• https://www.jamanetwork.com
• http://www.jamanetworkaudio.com
• https://www.facebook.com/JAMANetwork
• https://www.twitter.com/JAMANetwork
• https://www.instagram.com/JAMANetwork
• https://www.pinterest.com/JAMANetwork
=====================================================================
#JAMALive #Coronavirus #COVID19 #SARSCoV2 #Pandemic
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.